Testing a new approach to supporting people with bronchiectasis to take prescribed inhaled antibiotics

Completed

• Conditions: Suboptimal adherence to inhaled antibiotics in bronchiectasis; Respiratory; Bronchiectasis

• Registration Number: ISRCTN21712871
• Lead Sponsor: Queen's University Belfast

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-01-05
• Last Update Posted: 6 February 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

1. Aged over 18 years
2. Diagnosed with non-cystic fibrosis bronchiectasis through computed tomography (CT) or high-resolution CT (HRCT)
3. Prescribed inhaled antibiotics (specifically colistimethate sodium) for chronic suppression of P. aeruginosa
4. Have suboptimal adherence

Exclusion Criteria

1. Those who cannot consent to take part or do not have the ability to complete study questionnaires
2. People who self-report full adherence, as measured using a validated self-reported adherence questionnaire

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determination of the extent to which the intervention has been delivered as intended, measured by review of completed Participant Intervention Records. For each completed record, the project team will determine the proportion of instructions completed as described in the manual. Errors of omission and deviations to the planned delivery of the intervention will be identified by researcher recall and crosschecked with audio recordings of visits with patients. Reasons for deviations will be discussed with the study team and reported. Measured within one month of intervention delivery.